Schedule 13D ownership disclosure
ACASTI PHARMA INC
Security class unavailable · CUSIP: 00430K105
Event date: 2014-05-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 47.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-15-314774
- Form type
- SC 13D
- Filer
- Grace Therapeutics, Inc.
- CIK
- CIK 1444192
- Filed
- Sep 09, 2015
- Reporting period
- May 31, 2014
- Description
- Schedule 13D beneficial ownership